Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT<sub>2A</sub> Receptor Agonists.

Pottie E, Poulie CBMiD, Simon IAiD, Harpsøe KiD, D'Andrea LiD, Komarov IViD, Gloriam DEiD, Jensen AAiD, Kristensen JLiD, Stove CPiD

ACS chemical neuroscienceJul 20, 2023License: open accessBelgium, Denmark24 citationsDOI: 10.1021/acschemneuro.3c00267

Abstract

Serotonergic psychedelics are described to have activation of the serotonin 2A receptor (5-HT<sub>2A</sub>) as their main pharmacological action. Despite their relevance, the molecular mechanisms underlying the psychedelic effects induced by certain 5-HT<sub>2A</sub> agonists remain elusive. One of the proposed hypotheses is the occurrence of biased agonism, defined as the preferential activation of certain signaling pathways over others. This study comparatively monitored the efficiency of a diverse panel of 4-position-substituted (and <i>N</i>-benzyl-derived) phenylalkylamines to induce recruitment of β-arrestin2 (βarr2) or miniGα<sub>q</sub> to the 5-HT<sub>2A</sub>, allowing us to assess structure-activity relationships and biased agonism. All test compounds exhibited agonist properties with a relatively large range of both EC<sub>50</sub> and <i>E</i><sub>max</sub> values. Interestingly, the lipophilicity of the 2C-X phenethylamines was correlated with their efficacy in both assays but yielded a stronger correlation in the miniGα<sub>q</sub>- than in the βarr2-assay. Molecular docking suggested that accommodation of the 4-substituent of the 2C-X analogues in a hydrophobic pocket between transmembrane helices 4 and 5 of 5-HT<sub>2A</sub> may contribute to this differential effect. Aside from previously used standard conditions (lysergic acid diethylamide (LSD) as a reference agonist and a 2 h activation profile to assess a compound's activity), serotonin was included as a second reference agonist, and the compounds' activities were also assessed using the first 30 min of the activation profile. Under all assessed circumstances, the qualitative structure-activity relationships remained unchanged. Furthermore, the use of two reference agonists allowed for the estimation of both "benchmark bias" (relative to LSD) and "physiology bias" (relative to serotonin).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

LSD

Keywords

5-ht2aBiased AgonismΒ-arrestinPsychedelicsIn Vitro PharmacologyMinigαq

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.